How to Check Nephro Care IPO Allotment Status Online:
Let’s now address the million-dollar question: How can you check the IPO allotment status?
For NSE SME IPOs, you can’t check the allotment status on the exchange website because the NSE doesn’t provide that facility. Similarly, the BSE only offers allotment status for mainboard IPOs and BSE SME IPOs.
If you have applied for the IPO, you can check your allotment status on the website of the IPO registrar, Link Intime India Private Limited. Here are the steps you need to follow:
- Visit the Link Intime India Private Limited website.
- Navigate to the IPO allotment status section.
- Enter the required details (such as your PAN, application number, or DP/Client ID).
- Submit the information to view your allotment status
Checking the Nephro Care IPO allotment status on Link Intime
If you’re opening an account for an IPO within the first 10 minutes, click here.
To check the Nephro Care IPO allotment status on Link Intime, follow these steps:
-
- Visit the Link Intime Website: Go to the Link website.
- Enter Required Details:
- PAN: Enter your Permanent Account Number.
- Application Number: Enter the application number you received when you applied for the IPO.
- DP/Client ID: If applicable, enter your Depository Participant and Client ID.
- Navigate to the IPO Allotment Status Section: Look for the section or tab that deals with IPO allotment status. This is often found under the “Investor Services” or “IPO” section.
- Select Nephro Care IPO: From the list of IPOs, select “Nephro Care IPO.”
- Submit Information: After entering the necessary details, click on the “Submit” button.
- View Allotment Status: The website will display your allotment status for the Nephro Care IPO.
If you have any issues or require further assistance, you can contact our customer support.
Here are three methods to check your IPO allotment status:
- Click the Hyperlink: Simply click on the provided hyperlink to go directly to the allotment checking page.
- Copy and Paste the Link: If clicking the link isn’t working, copy the URL and paste it into your web browser’s address bar.
- Access via Link Intime’s Home Page: Go to the Link Intime India Private Limited homepage and click on the “Public Issues” link prominently displayed there.
Once the allotment status is finalized, only active IPOs will be shown in the dropdown menu. For Nephro Care Sales, you can check the allotment status late on July 03, 2024, or by mid-July 04, 2024.
On the allotment status page, you have four options to choose from:
- PAN Number: Enter your 10-character Permanent Account Number (PAN), which is an alphanumeric code found on your PAN card or at the top of your income tax return.
- Application Number: Use the application number provided to you during the IPO application process.
- DPID/Client ID Combination: Enter your DP ID and demat client ID as a single string. This combination is numeric for CDSL demat accounts and alphanumeric for NSDL demat accounts. You can find these details in your demat statement or through your online trading account or app.
- Bank Account/IFSC Code Combination: Enter the bank account number and the 11-character IFSC code used for your IPO application. The IFSC code can be found on your cheque book, with the first four characters being alphabets and the last seven characters numeric.
After entering the required details, click the “Search” button to view your allotment status. The number of shares allotted to you for the Nephro Care Sales IPO will be displayed on the screen. You can take a screenshot of this page for your records and later reconcile it with your demat account when the shares are credited on July 04, 2024.
The success of your IPO allotment depends on the allocation quota and subscription levels.
Allocation quota and subscription levels for Nephro Care Sales
The following table details the quota distribution for different categories, including the number of shares and the percentage of the total share capital raised. For investors, the quotas allocated to retail and High Net-Worth Individuals (HNI) are particularly significant.
| Investor Category | Shares Allocated in the IPO |
| Reserved for Eligible Employees | 2,25,600 shares (4.92% of total issue size) |
| Market Maker Shares | 2,30,400 shares (5.02% of total issue size) |
| Anchor Portion Allocation | 12,38,400 shares (27.02% of total issue size) |
| QIB Shares Offered | 8,25,600 shares (18.01% of total issue size) |
| NII (HNI) Shares Offered | 6,19,200 shares (13.51% of total issue size) |
| Retail Shares Offered | 14,44,800 shares (31.52% of total issue size) |
| Total Shares Offered | 45,84,000 shares (100.00% of total issue size) |
Data Source: Company RHP
The IPO of Nephro Care India received overwhelming response, achieving an overall subscription rate of 715.86 times by the close of bidding on July 2, 2024. The HNI (High Net Worth Individual) and NII (Non-Institutional Investor) segment subscribed 1,787.56 times, while the Retail segment subscribed 634.13 times. The QIB (Qualified Institutional Buyer) quota also saw strong demand, reaching 245.14 times its allocated quota. The following table summarizes the allocation of shares and oversubscription details as of the IPO’s closure on July 2, 2024. The IPO remained open for a period of 3 trading days.
| Investor Category |
Subscription (times) | Shares Offered | Shares bid for |
Total Amount (₹ in Crore) |
| Anchor Investors | 1.00 | 12,38,400 | 12,38,400 | 11.15 |
| Market Maker | 1.00 | 2,30,400 | 2,30,400 | 2.07 |
| Employee Quota | 20.44 | 2,25,600 | 46,11,200 | 41.50 |
| QIB Investors | 245.14 | 8,25,600 | 20,23,87,200 | 1,821.48 |
| HNIs / NIIs | 1,787.56 | 6,19,200 | 1,10,68,56,000 | 9,961.70 |
| Retail Investors | 634.13 | 14,44,800 | 91,61,84,000 | 8,245.66 |
| Total | 715.86 | 31,15,200 | 2,23,00,38,400 | 20,070.35 |
Data Source: NSE
In the above case, the subscription is extremely robust and strong for retail and HNI / NII, and that largely makes the chances of allotment in the IPO substantially lower. This subscription is much higher than the median subscription that NSE-SME IPOs generally get to see.
Timeline and Considerations for Nephro Care India IPO
- Subscription Period: The IPO subscription period commenced on June 28, 2024, and concluded on July 2, 2024 (inclusive).
- Basis of Allotment: The basis of allotment is scheduled to be finalized on July 3, 2024.
- Refunds: Refunds for unsuccessful applicants will be initiated on July 4, 2024.
- Demat Credits: Demat credits for allotted shares are also expected to occur on July 4, 2024.
- Listing Date: Nephro Care India’s stock is set to list on the SME segment of the NSE on July 5, 2024.
- Demat Account Credits: Shares allotted will be credited to investors’ demat accounts by the close of July 4, 2024, under ISIN (INE0SUN01013).
Investors should note that the subscription level significantly influences the allotment process. Higher subscription ratios typically lower the chances of allotment, and vice versa. Given the high subscription levels observed in both the Retail and HNI/NII segments of this IPO, investors are advised to assess their allotment prospects accordingly. The final allotment status will be available post the finalization and upload of the basis of allotment, enabling investors to verify their allocation.
Overview of Nephro Care India IPO
- Stock Details: Nephro Care India shares have a face value of ₹10 per share and are offered through a book built issue.
- Price Band: The price band for the book building process is set between ₹85 to ₹90 per share, with the final price determined within this range.
- Issue Composition: The IPO consists solely of a fresh issue of shares, with no offer for sale (OFS) component involved.
- Impact on EPS and Equity: The fresh issue portion, being EPS and equity dilutive, involves issuing 45,84,000 shares (45.84 lakh shares) at ₹90 per share, raising ₹41.26 crore. Post-issue, the promoter’s equity holding will reduce from 85.02% to 61.38%.
- Market Making: A market making portion of 2,30,400 shares is allocated to ensure liquidity, managed by SS Corporate Securities Ltd.
- Promoters and Usage of Funds: Founded by Dr. Pratim Sengupta, the IPO proceeds will primarily fund the establishment of the “Vivacity Multi-Specialty Hospital” focusing on nephro care, alongside provisions for general corporate purposes.
- Key Participants: Corporate Capital Ventures Private Ltd serves as the lead manager, while Bigshare Services Private Ltd is the registrar. The market maker for the issue is yet to be announced.
- Listing Venue: Nephro Care India’s IPO will list on the SME IPO segment of the NSE, enhancing its visibility and trading opportunities.
